Copyright Reports & Markets. All rights reserved.

Global B2B Mold Inhibitors Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global B2B Mold Inhibitors Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Powder
    • 1.3.3 Coating
    • 1.3.4 Masterbatch
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global B2B Mold Inhibitors Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Plastics and Polymers
    • 1.4.3 Textile
    • 1.4.4 Building Material and Exterior Wall
    • 1.4.5 Housing Equipment
    • 1.4.6 Others
  • 1.5 Global B2B Mold Inhibitors Market Size & Forecast
    • 1.5.1 Global B2B Mold Inhibitors Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global B2B Mold Inhibitors Sales Quantity (2021-2032)
    • 1.5.3 Global B2B Mold Inhibitors Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sanitized
    • 2.1.1 Sanitized Details
    • 2.1.2 Sanitized Major Business
    • 2.1.3 Sanitized B2B Mold Inhibitors Product and Services
    • 2.1.4 Sanitized B2B Mold Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sanitized Recent Developments/Updates
  • 2.2 Guangdong Dimei Biological Technology
    • 2.2.1 Guangdong Dimei Biological Technology Details
    • 2.2.2 Guangdong Dimei Biological Technology Major Business
    • 2.2.3 Guangdong Dimei Biological Technology B2B Mold Inhibitors Product and Services
    • 2.2.4 Guangdong Dimei Biological Technology B2B Mold Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Guangdong Dimei Biological Technology Recent Developments/Updates
  • 2.3 Sinanen Zeomic
    • 2.3.1 Sinanen Zeomic Details
    • 2.3.2 Sinanen Zeomic Major Business
    • 2.3.3 Sinanen Zeomic B2B Mold Inhibitors Product and Services
    • 2.3.4 Sinanen Zeomic B2B Mold Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sinanen Zeomic Recent Developments/Updates
  • 2.4 3D Bio-chem
    • 2.4.1 3D Bio-chem Details
    • 2.4.2 3D Bio-chem Major Business
    • 2.4.3 3D Bio-chem B2B Mold Inhibitors Product and Services
    • 2.4.4 3D Bio-chem B2B Mold Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 3D Bio-chem Recent Developments/Updates
  • 2.5 Thermaset
    • 2.5.1 Thermaset Details
    • 2.5.2 Thermaset Major Business
    • 2.5.3 Thermaset B2B Mold Inhibitors Product and Services
    • 2.5.4 Thermaset B2B Mold Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Thermaset Recent Developments/Updates
  • 2.6 iHeir
    • 2.6.1 iHeir Details
    • 2.6.2 iHeir Major Business
    • 2.6.3 iHeir B2B Mold Inhibitors Product and Services
    • 2.6.4 iHeir B2B Mold Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 iHeir Recent Developments/Updates
  • 2.7 Daiko Technical
    • 2.7.1 Daiko Technical Details
    • 2.7.2 Daiko Technical Major Business
    • 2.7.3 Daiko Technical B2B Mold Inhibitors Product and Services
    • 2.7.4 Daiko Technical B2B Mold Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Daiko Technical Recent Developments/Updates
  • 2.8 Colloids
    • 2.8.1 Colloids Details
    • 2.8.2 Colloids Major Business
    • 2.8.3 Colloids B2B Mold Inhibitors Product and Services
    • 2.8.4 Colloids B2B Mold Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Colloids Recent Developments/Updates
  • 2.9 I'm Biotechnology
    • 2.9.1 I'm Biotechnology Details
    • 2.9.2 I'm Biotechnology Major Business
    • 2.9.3 I'm Biotechnology B2B Mold Inhibitors Product and Services
    • 2.9.4 I'm Biotechnology B2B Mold Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 I'm Biotechnology Recent Developments/Updates
  • 2.10 Guangzhou Good Nice Anti-Mold
    • 2.10.1 Guangzhou Good Nice Anti-Mold Details
    • 2.10.2 Guangzhou Good Nice Anti-Mold Major Business
    • 2.10.3 Guangzhou Good Nice Anti-Mold B2B Mold Inhibitors Product and Services
    • 2.10.4 Guangzhou Good Nice Anti-Mold B2B Mold Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Guangzhou Good Nice Anti-Mold Recent Developments/Updates
  • 2.11 Suzhou Anmei Material Technology
    • 2.11.1 Suzhou Anmei Material Technology Details
    • 2.11.2 Suzhou Anmei Material Technology Major Business
    • 2.11.3 Suzhou Anmei Material Technology B2B Mold Inhibitors Product and Services
    • 2.11.4 Suzhou Anmei Material Technology B2B Mold Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Suzhou Anmei Material Technology Recent Developments/Updates

3 Competitive Environment: B2B Mold Inhibitors by Manufacturer

  • 3.1 Global B2B Mold Inhibitors Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global B2B Mold Inhibitors Revenue by Manufacturer (2021-2026)
  • 3.3 Global B2B Mold Inhibitors Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of B2B Mold Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 B2B Mold Inhibitors Manufacturer Market Share in 2025
    • 3.4.3 Top 6 B2B Mold Inhibitors Manufacturer Market Share in 2025
  • 3.5 B2B Mold Inhibitors Market: Overall Company Footprint Analysis
    • 3.5.1 B2B Mold Inhibitors Market: Region Footprint
    • 3.5.2 B2B Mold Inhibitors Market: Company Product Type Footprint
    • 3.5.3 B2B Mold Inhibitors Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global B2B Mold Inhibitors Market Size by Region
    • 4.1.1 Global B2B Mold Inhibitors Sales Quantity by Region (2021-2032)
    • 4.1.2 Global B2B Mold Inhibitors Consumption Value by Region (2021-2032)
    • 4.1.3 Global B2B Mold Inhibitors Average Price by Region (2021-2032)
  • 4.2 North America B2B Mold Inhibitors Consumption Value (2021-2032)
  • 4.3 Europe B2B Mold Inhibitors Consumption Value (2021-2032)
  • 4.4 Asia-Pacific B2B Mold Inhibitors Consumption Value (2021-2032)
  • 4.5 South America B2B Mold Inhibitors Consumption Value (2021-2032)
  • 4.6 Middle East & Africa B2B Mold Inhibitors Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global B2B Mold Inhibitors Sales Quantity by Type (2021-2032)
  • 5.2 Global B2B Mold Inhibitors Consumption Value by Type (2021-2032)
  • 5.3 Global B2B Mold Inhibitors Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global B2B Mold Inhibitors Sales Quantity by Application (2021-2032)
  • 6.2 Global B2B Mold Inhibitors Consumption Value by Application (2021-2032)
  • 6.3 Global B2B Mold Inhibitors Average Price by Application (2021-2032)

7 North America

  • 7.1 North America B2B Mold Inhibitors Sales Quantity by Type (2021-2032)
  • 7.2 North America B2B Mold Inhibitors Sales Quantity by Application (2021-2032)
  • 7.3 North America B2B Mold Inhibitors Market Size by Country
    • 7.3.1 North America B2B Mold Inhibitors Sales Quantity by Country (2021-2032)
    • 7.3.2 North America B2B Mold Inhibitors Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe B2B Mold Inhibitors Sales Quantity by Type (2021-2032)
  • 8.2 Europe B2B Mold Inhibitors Sales Quantity by Application (2021-2032)
  • 8.3 Europe B2B Mold Inhibitors Market Size by Country
    • 8.3.1 Europe B2B Mold Inhibitors Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe B2B Mold Inhibitors Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific B2B Mold Inhibitors Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific B2B Mold Inhibitors Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific B2B Mold Inhibitors Market Size by Region
    • 9.3.1 Asia-Pacific B2B Mold Inhibitors Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific B2B Mold Inhibitors Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America B2B Mold Inhibitors Sales Quantity by Type (2021-2032)
  • 10.2 South America B2B Mold Inhibitors Sales Quantity by Application (2021-2032)
  • 10.3 South America B2B Mold Inhibitors Market Size by Country
    • 10.3.1 South America B2B Mold Inhibitors Sales Quantity by Country (2021-2032)
    • 10.3.2 South America B2B Mold Inhibitors Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa B2B Mold Inhibitors Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa B2B Mold Inhibitors Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa B2B Mold Inhibitors Market Size by Country
    • 11.3.1 Middle East & Africa B2B Mold Inhibitors Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa B2B Mold Inhibitors Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 B2B Mold Inhibitors Market Drivers
  • 12.2 B2B Mold Inhibitors Market Restraints
  • 12.3 B2B Mold Inhibitors Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of B2B Mold Inhibitors and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of B2B Mold Inhibitors
  • 13.3 B2B Mold Inhibitors Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 B2B Mold Inhibitors Typical Distributors
  • 14.3 B2B Mold Inhibitors Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global B2B Mold Inhibitors market size was valued at US$ 182 million in 2025 and is forecast to a readjusted size of US$ 257 million by 2032 with a CAGR of 5.1% during review period.
    B2B Mold Inhibitors are mold inhibitors specifically designed for industrial and commercial applications, and are primarily sold to other businesses rather than end consumers. These products are often used to protect a variety of materials and products from mold and fungi, especially in humid or hot environments. B2B mold inhibitors can be used in a variety of industries, such as textiles, leather, wood, paper, plastics, coatings, adhesives, etc., to help companies extend product life, maintain product quality, and reduce losses caused by mold growth.
    Innovations in biotechnology and chemical engineering are leading to the development of more effective and efficient mold inhibitors. These advancements are enabling companies to offer products with longer shelf lives and better performance under various conditions.
    This report is a detailed and comprehensive analysis for global B2B Mold Inhibitors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global B2B Mold Inhibitors market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
    Global B2B Mold Inhibitors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
    Global B2B Mold Inhibitors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
    Global B2B Mold Inhibitors market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for B2B Mold Inhibitors
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global B2B Mold Inhibitors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanitized, Guangdong Dimei Biological Technology, Sinanen Zeomic, 3D Bio-chem, Thermaset, iHeir, Daiko Technical, Colloids, I'm Biotechnology, Guangzhou Good Nice Anti-Mold, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    B2B Mold Inhibitors market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Powder
    Coating
    Masterbatch
    Market segment by Application
    Plastics and Polymers
    Textile
    Building Material and Exterior Wall
    Housing Equipment
    Others
    Major players covered
    Sanitized
    Guangdong Dimei Biological Technology
    Sinanen Zeomic
    3D Bio-chem
    Thermaset
    iHeir
    Daiko Technical
    Colloids
    I'm Biotechnology
    Guangzhou Good Nice Anti-Mold
    Suzhou Anmei Material Technology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe B2B Mold Inhibitors product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of B2B Mold Inhibitors, with price, sales quantity, revenue, and global market share of B2B Mold Inhibitors from 2021 to 2026.
    Chapter 3, the B2B Mold Inhibitors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the B2B Mold Inhibitors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and B2B Mold Inhibitors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of B2B Mold Inhibitors.
    Chapter 14 and 15, to describe B2B Mold Inhibitors sales channel, distributors, customers, research findings and conclusion.

    Buy now